Audhya Paul K.

CIK 00018601311 companyFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001860131

Recent Transactions

50 trades

Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-01-16+100,000→ 100,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−5,296→ 131,831 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 137,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 132,127 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-18$14.48/sh−3,075→ 125,877 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−4,028→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-17+6,447→ 128,952 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−2,419→ 4,838 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-25$13.42/sh−2,336→ 122,505 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22$13.22/sh−2,942→ 119,841 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22+5,000→ 124,841 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-22−5,000→ 55,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-21+6,250→ 122,783 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-21−6,250→ 87,500 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-18$13.19/sh−2,939→ 116,533 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−4,028→ 4,028 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-17+6,446→ 119,472 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−2,418→ 7,257 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-23$11.31/sh−2,146→ 113,026 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-22−5,000→ 60,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-22$11.88/sh−2,689→ 110,172 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-22+5,000→ 115,172 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-21+6,250→ 112,861 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-21−6,250→ 93,750 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-19$11.84/sh−2,776→ 106,611 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-17+6,447→ 109,387 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−4,028→ 8,056 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−2,419→ 9,675 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-24$10.02/sh−2,394→ 102,940 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-22+5,000→ 105,334 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-22−5,000→ 65,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Units
2025-02-21+100,000→ 100,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-18$9.82/sh−3,125→ 100,334 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-02-17+6,447→ 103,459 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-17−4,028→ 12,084 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-02-17−2,419→ 12,094 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-26$9.87/sh−2,187→ 97,012 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-22−5,000→ 70,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-22+5,000→ 99,199 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-18$9.26/sh−8,077→ 94,199 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-17−4,028→ 16,112 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Performance Stock Units
2024-11-17−12,084→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-11-17+18,531→ 102,276 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-11-17−2,419→ 14,513 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-08-23$12.40/sh−2,135→ 83,745 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-08-22+5,000→ 85,880 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2024-08-22−5,000→ 75,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2024-08-19$12.01/sh−7,973→ 80,880 total

Companies

KalVista Pharmaceuticals, Inc.
CHIEF MEDICAL OFFICER
$KALV

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov